Sailong Pharmaceutical Group Co., Ltd.
SZSE:002898.SZ
12.44 (CNY) • At close October 26, 2023
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -33.146 | 9.534 | -37.312 | -23.341 | -67.222 | 27.483 | 60.905 | 64.505 | 61.249 | 63.318 | 28.191 | 45.877 |
| Afschrijvingen & Amortisatie
| 34.248 | 32.665 | 34.062 | 32.797 | 29.294 | 20.029 | 14.222 | 10.017 | 8.234 | 6.023 | 5.348 | 4.285 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 7.573 | 4.006 | 14.556 | -17.165 | -11.677 | 0.757 | -2 | 2.276 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.58 | 25.415 | 0 |
| Verandering in Werkkapitaal
| -70.436 | 4.114 | 16.393 | 28.772 | 64.865 | -94.537 | -74.906 | 10.505 | 6.326 | -23.302 | -8.066 | -2.811 |
| Vorderingen
| -36.639 | 60.684 | -5.024 | -10.335 | 54.112 | -52.194 | -54.625 | -41.884 | 15.233 | -13.43 | 18.995 | 0 |
| Voorraden
| -19.244 | -28.848 | -15.89 | 6.514 | -12.862 | -7.356 | -20.157 | 11.062 | -12.789 | -11.863 | -0.788 | -10.906 |
| Crediteuren
| 0 | -27.375 | 29.734 | 28.587 | 9.06 | -17.822 | 11.552 | 40.57 | 5.882 | -0.284 | 0 | 0 |
| Overig Werkkapitaal
| -14.553 | -0.347 | 7.573 | 4.006 | 14.556 | -17.165 | -54.749 | -0.556 | 19.115 | -11.439 | -7.278 | 8.095 |
| Overige Niet-Contante Posten
| 30.473 | -10.605 | 0.982 | -2.767 | -26.763 | 0.509 | 3.107 | 0.099 | 2.844 | 1.4 | 25.889 | 17.491 |
| Kasstroom uit Operationele Activiteiten
| -38.861 | 35.707 | 14.125 | 35.461 | 0.175 | -46.515 | 3.328 | 85.126 | 78.653 | 47.439 | 51.363 | 64.842 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -34.667 | -30.579 | -23.942 | -31.473 | -64.057 | -111.726 | -134.839 | -94.378 | -51.434 | -47.239 | -35.741 | -5.551 |
| Netto Overnames
| 0 | 1.782 | 3.239 | 7 | 0 | -0 | 0 | 0 | 0.002 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -168.807 | -155.002 | 0 | -60 | -45.15 | -230 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 171.055 | 153.22 | 0 | 60.393 | 40.067 | 232.186 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 19.776 | 11.253 | 2.353 | 1.6 | 0.884 | 0.91 | 2.63 | 2.489 | 1.575 | 0.919 | 0.56 | 0.4 |
| Kasstroom uit Investeringsactiviteiten
| -12.643 | -19.325 | -18.351 | -22.48 | -68.256 | -108.63 | -132.208 | -91.889 | -49.858 | -46.32 | -35.181 | -5.151 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| 37.217 | -15.954 | -28.786 | 51.66 | 41.711 | 78.289 | -15 | 15 | 0 | -10 | -12 | 22 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | -1.12 | -10.559 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -8.453 | -5.579 | -8.695 | -7.891 | -4.8 | -32 | -16 | -14.971 | -26.588 | -46.547 | -33.224 | -30.451 |
| Overige Financieringsactiviteiten
| -14.398 | 19.653 | -0.914 | -1.271 | -0.373 | -1.752 | -1.538 | 311.703 | -0.035 | 72.366 | -0.029 | -0.027 |
| Kasstroom uit Financieringsactiviteiten
| 14.366 | -1.88 | -38.447 | 42.498 | 29.703 | 44.537 | -32.538 | 301.127 | -26.623 | 15.819 | -45.253 | -8.478 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | -0 | 0 | -0 | 0 | -0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -37.139 | 14.502 | -42.673 | 55.48 | -38.378 | -110.608 | -161.418 | 294.364 | 2.171 | 16.938 | -29.072 | 51.214 |
| Kaspositie aan het Einde van de Periode
| 47.967 | 85.106 | 70.604 | 113.277 | 57.798 | 96.176 | 206.784 | 368.202 | 73.838 | 71.667 | 54.729 | 83.8 |